Frailty assessments are important predictors of future health outcomes among geriatric patients with hematologic malignancies.
These assessments, usually performed in clinics, became much more challenging during the COVID-19 pandemic due to the elevated risk for infection that older patients with blood cancers faced. As has been the case in many areas of medicine, this challenge has been met in a manner that will likely endure beyond the pandemic — through telehealth.
Researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute focused on the use of virtual